LoginRegister

    Alembic Pharma sells its Baddi unit to Scott Edil Pharmacia

    Written by Ruby Khatun Khatun   |  
    Alembic Pharma sells its Baddi unit to Scott Edil Pharmacia

    Mumbai: Pharma Firm, Alembic Pharmaceuticals (Alembic Pharma) has sold its formulations manufacturing facility at Baddi to Scott Edil Pharmacia (SEPL), the company said in a filing to the bourses on Wednesday.


    SEPL does not belong to the promoter or promoter group or group companies and is not a related party of the company. The turnover and net worth of the said manufacturing facility for the last financial year vis-à-vis turnover and net worth of the company is insignificant, the company added.


    The company continues to meet its domestic formulation demand from Sikkim Unit and international formulation demand from its Panelav Unit. Alembic Pharmaceuticals is engaged developing formulations and active pharmaceutical ingredients (API).


    The company focuses on anti-infective, analgesic and cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynaecology, gastrointestinal, orthopedic, dermatology, and ophthalmology.

    active pharmaceutical ingredientsAlembicAlembic PharmaAlembic Pharmaceuticalsanalgesicanti-infectiveBaddi unitcardiologyDermatologydiabetesgastrointestinalgynaecologyophthalmologyorthopedicsScott Edil PharmaciasellsSEPLturnover
    Source : UNI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X